Treatment details | 60 DAT | 80 DAT | ||
---|---|---|---|---|
Disease severity (%) | Disease reduction (%) over positive control | Disease severity (%) | Disease reduction (%) over positive control | |
T1-Funneliformis mosseae (FM) | 16.7 | 49.39 | 58.3 | 22.26 |
T2-Glomus fasciculatum (GF) | 25 | 24.24 | 58.3 | 22.26 |
T3-Bacillus velezensis (BV) | 8.4 | 74.54 | 41.67 | 44.45 |
T4-Bacillus sp. (Bs) | 25 | 24.24 | 50 | 33.34 |
T5-F. mosseae + B. velezensis (FM + BV) | 0 | 100 | 33.4 | 55.44 |
T6- F. mosseae + Bacillus sp. (FM + Bs) | 8.4 | 74.74 | 50 | 33.34 |
T7- G. fasciculatum + B. velezensis (GF + BV) | 16.7 | 49.39 | 50 | 33.34 |
T8- G. fasciculatum + Bacillus sp. (GF + Bs) | 8.4 | 74.54 | 41.67 | 44.45 |
T9- F. mosseae + B. velezensis + Bacillus sp. (FM + BV + Bs) | 0 | 100 | 25 | 66.67 |
T10- G. fasciculatum + B.velezensis + Bacillus sp. (GF + BV + Bs) | 16 | 51.51 | 41.67 | 44.45 |
T11-B. velezensis + F. mosseae + G. fasciculatum (BV + FM + GF) | 16 | 51.51 | 41.67 | 44.45 |
T12-Bacillus sp. + F. mosseae + G. fasciculatum (Bs + FM + GF) | 25 | 24.24 | 58.3 | 22.26 |
T13- F. mosseae + G. fasciculatum (FM + GF) | 16 | 51.51 | 41.67 | 44.45 |
T14- B. velezensis + Bacillus sp. (BV + Bs) | 0 | 100 | 25 | 66.67 |
T15- F. mosseae + G. fasciculatum + B. velezensis + Bacillus sp. (FM + GF + BV + Bs) | 0 | 100 | 16.7 | 77.44 |
T16-Negative control (without pathogen) (NC) | 0 | 100 | 0 | 100 |
T17-Positive control (only pathogen inoculated) (PC) | 33.00 | 0 | 75 | 0 |
T18-Carbendazim (Car.) | 0.00 | 100 | 8.4 | 88.9 |